Brainstorm Cell Therapeutics Inc. | TalkMarkets

Latest Posts

PLX Upcoming Volatility Creates Opportunity

Article By: Moon Kil Woong

Tuesday, July 27, 2021 9:01 AM EDT

PLX was up on FDA notice last year on a CRL postponement that its PDUFA review of PRX-102. In the meantime, phase III trials continue to provide more positive results. It is a stock worth watching.

In this article: PLX Also: INO, DYAI, BCLI, LFMD

Read

Dow Falls From Record High As Wall Street Takes A Breather

Article By: Schaeffers Research

Tuesday, November 17, 2020 12:18 PM EDT

Following yesterday's record highs, the Dow Jones Industrial Average (DJI) is down over 190 points midday.

In this article: TSLA, NDX, SPX, DJI, BCLI, FUBO, AMZN, WBA

Read

The Week Ahead In Biotech: J&J Earnings Kickstarts Pharma Earnings, More IPOs In The Pipeline

Article By: Benzinga

Sunday, October 11, 2020 2:26 PM EDT

Biotech stocks advanced along with the market in the past week, though the news flow was light. Antibody treatment for COVID-19 took the spotlight, with both Eli Lilly And Co and Regeneron Pharmaceuticals Inc requesting emergency use authorizations.